Wiki's Treatment for Stage Four Breast Cancer
To raise funds to purchase drugs to prolong the life of my wife and mother to our three children.Manawatu / Whanganui
Kia ora folks.
On May 31st 2018, the world of my small family was dealt a devastating blow. My wife, Wiki (40), and mother to our three children, Molly Rose (17), Ihaia (13) and Patrick (10), was diagnosed with Stage Four Breast Cancer.
Immediately Wiki was prescribed Tamoxifen but sadly after two months worth of treatment, the cancer had spread to her lungs. This means that currently she is now undergoing chemotherapy in the hope of stopping the disease from spreading further.
Eventually she will require Ibrance-Palbociblib, a CDK4/6 inhibitor that stops the growth of cancer for a period of time. However Ibrance is not subsidized by Pharmac and therefore the monthly cost of the drug is between $5800. Ibrance also requires the taking of another drug, Fulvestrant, that costs an additional $1000. That's a total cost of $6800 per month, not including an administration fee that is charged also.
At the insistence of family and friends, we have set up this Give a Little page to raise funds for the purchase of Ibrance. On behalf of our family, our heartfelt thanks for taking the time to read this page and for anybody able to contribute towards the cost of drugs that will prolong Wiki's life, enabling her to spend more time with family and friends.
Malcolm Mulholland's involvement (page creator)
Wiki is my wife who has Stage Four Breast Cancer.
Use of funds
The money will be spent to purchase Ibrance-Palbociblib and associated medical costs.
Kia ora everybody.
We have had to reopen Wiki's Givealittle Page, as she is now taking an unfunded chemotherapy drug called Abraxane. This costs over $5000 per month. Again, funds raised will go towards Wiki's treatment and care. Thank you.
FundraiseYou can start a fundraiser to have your own page that raises money directly for the beneficiary.
Got a question for the page owner?Ask one here
Any concerns?Report this page
This page was created on 21 Aug 2018 and closes on 21 Aug 2020.